CYTOKINETICS INC (CYTK)       42.05  -1.07 (-2.48%)

42.05  -1.07 (-2.48%)

US23282W6057 - Common Stock

News Image
5 hours ago - Cytokinetics, Incorporated

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

Total of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach...

News Image
26 days ago - Cytokinetics, Incorporated

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 30, 2022 it...

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President...

News Image
a month ago - BusinessInsider

These 3 “Strong Buy” Stocks Can Be Great Choices for 2023

One shouldn’t keep a myopic view of the market while building a strong and sustainable portfolio. Gains and losses are averaged out over a long...

News Image
2 months ago - Bloomberg

Cytokinetics Jumps Despite Negative FDA Panel Vote on Heart Drug

Cytokinetics Inc.’s experimental heart failure drug got a negative vote from a panel of expert advisors to the US Food and Drug Administration. But, in a twist, shares are rising.

News Image
2 months ago - Investor's Business Daily

Why Cytokinetics Is Soaring After A 'Bruising' FDA Meeting For Its Heart Drug

The FDA's experts voted 3-8 against the Cytokinetics heart-failure drug.

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

PDUFA Target Action Date is February 28, 2023 Cytokinetics to Host Conference Call and Webcast on December 14, 2022 at 8:30 am Eastern Time SOUTH SAN...

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Stock Trading Halted Today

FDA Advisory Committee to Review the New Drug Application for Omecamtiv Mecarbil for the Treatment of Heart Failure with Reduced Ejection Fraction...

News Image
2 months ago - Seeking Alpha

CYTK stock dips as FDA posts briefing documents on heart failure therapy (NASDAQ:CYTK)

Cytokinetics (CYTK) fell on Friday after the FDA briefing documents ahead of an advisory committee meeting on its heart failure therapy omecamtiv mecarbil. Read full story here.

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug...

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

Analysis from FORTITUDE-ALS Shows Predicted Survival Risk Score Strongly Correlated with Decline in ALSFRS-R Findings Suggest Inclusion Criteria for...

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

Advancement of Novel Cardiac Troponin Activator Expands Cardiovascular Franchise for Conditions Associated with Impaired Cardiac Contractility...

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2022 it...

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced one poster presentation at the...

News Image
3 months ago - Cytokinetics, Incorporated

Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from two additional...